e-learning
resources
London 2016
Saturday, 03.09.2016
PG13 Inhaled antibiotics in respiratory infections
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?
Wim G. Boersma (Alkmaar, Netherlands)
Source:
International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Session:
PG13 Inhaled antibiotics in respiratory infections
Session type:
Postgraduate Course
Number:
144
Disease area:
Paediatric lung diseases, Respiratory infections
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Wim G. Boersma (Alkmaar, Netherlands). Inhaled antibiotics in non-cystic fibrosis bronchiectasis: better than oral antibiotics?. International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
ERS statement for defining respiratory exacerbations in children and adolescents with bronchiectasis for clinical trials
Cystic fibrosis and intestinal organoids
Related content which might interest you:
Inhaled antibiotics in cystic fibrosis: what we should do and what we still do not know
Source: International Congress 2016 – PG13 Inhaled antibiotics in respiratory infections
Year: 2016
Prescription of Inhaled corticosteroid in non-cystic fibrosis bronchiectasis:a solution or a problem
Source: Virtual Congress 2020 – News on clinical evaluation of bronchiectasis, cough and inflammatory disease
Year: 2020
Inhaled steroids in children with non-cystic fibrosis bronchiectasis
Source: Eur Respir J 2004; 24: Suppl. 48, 392s
Year: 2004
Inhaled antibiotics for stable non-cystic fibrosis bronchiectasis: a systematic review
Source: Eur Respir J 2014; 44: 382-393
Year: 2014
Inhaled antimicrobials
Source: ERS webinar 2020: Inhaled antimicrobials
Year: 2020
Aerozolized colistin therapy in non-cystic fibrosis patients with bronchiectasis
Source: Eur Respir J 2001; 18: Suppl. 33, 266s
Year: 2001
Inhaled colistin following lung transplantation in colonised cystic fibrosis patients
Source: Eur Respir J 2013; 42: 542-544
Year: 2013
Long-term administration of aerosolised tobramycin in patients with cystic fibrosis
Source: Eur Respir J 2005; 26: Suppl. 49, 619s
Year: 2005
Effects of long-term azithromycin treatment in patients with non-cystic fibrosis stable bronchiectasis
Source: Annual Congress 2007 - Infectious lung and pleural diseases
Year: 2007
Inhaled therapy in cystic fibrosis: agents, devices and regimens
Source: Breathe 2015; 11:110-118
Year: 2015
Inhaled colistin in elderly patients with bronchiectasis and chronic bronchial infection with pseudomonas
Source: Annual Congress 2012 - Management of severe respiratory infections
Year: 2012
Inhaled colistin in patients with non - cystic fibrosis bronchiectasis and chronic pseudomonas aeruginosa bronquial infection
Source: International Congress 2016 – Possible phenotypes of bronchiectasis and exacerbations
Year: 2016
Inhaled mannitol as treatment for children with cystic fibrosis
Source: Annual Congress 2008 - The use of inhaled mannitol for assessing airway disease
Year: 2008
Resistance to antimicrobial agents in patients with non-cystic fibrosis (CF) bronchiectasis
Source: Eur Respir J 2005; 26: Suppl. 49, 640s
Year: 2005
Evaluation of inhaled dry powder tobramycin free base in non-cystic fibrosis bronchiectasis patients
Source: International Congress 2016 – Clinical and microbiological aspects of bronchiectasis and non-tuberculous mycobacterium (NTM) infections
Year: 2016
Bronchospasm secondary to nebulised antibiotics in bronchiectasis
Source: International Congress 2017 – Bronchiectasis and NTM infections: epidemiology, phenotyping and therapeutic strategies
Year: 2017
Antibiotic treatment strategies in adults with bronchiectasis
Source: Eur Respir Mon 2011; 52: 211-222
Year: 2011
Once-daily tobramycin in the treatment of adult patients with cystic fibrosis
Source: Eur Respir J 2002; 19: 303-309
Year: 2002
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept